BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28052946)

  • 1. Dabigatran-related leukocytoclastic vasculitis.
    An J; Garje R; Wanat KA; Leone JP
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28052946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of leukocytoclastic vasculitis caused by novel anticoagulant rivaroxaban.
    Dean R; Messer AM; Pickett M; Jahan-Tigh R
    Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible apixaban-induced leukocytoclastic vasculitis.
    Daul B; Petersen G; Butler J
    Am J Health Syst Pharm; 2020 Aug; 77(17):1389-1392. PubMed ID: 32789435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of clomiphene-induced leukocytoclastic vasculitis.
    Garg Y; Jain S; Kumar A
    J Basic Clin Physiol Pharmacol; 2019 Jul; 30(4):. PubMed ID: 31343980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous leukocytoclastic vasculitis associated with anti-tuberculosis drugs.
    Avcu G; Sensoy G; Çeliksoy MH; Sogut A; Kefeli M; Karli A; Belet N
    Pediatr Int; 2015; 57(1):155-7. PubMed ID: 25711253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran.
    Leung TS; Law EH
    Drug Des Devel Ther; 2015; 9():3557-69. PubMed ID: 26185422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of glyburide-induced leukocytoclastic vasculitis.
    Henley JK; Blackmon JA; Fraga GR; Rajpara A; Maz M
    Dermatol Online J; 2013 Sep; 19(9):19619. PubMed ID: 24050293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocytoclastic vasculitis resolution with topical dapsone.
    Pate DA; Johnson LS; Tarbox MB
    Cutis; 2017 Jun; 99(6):426-428. PubMed ID: 28686752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate.
    Ageno W; Casella IB; Han CK; Raskob GE; Schellong S; Schulman S; Singer DE; Kimura K; Tang W; Desch M; Goldhaber SZ
    Thromb Haemost; 2017 Jan; 117(2):415-421. PubMed ID: 27853808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dabigatran in clinical practice: Contemporary overview of the evidence.
    Ageno W; Eikelboom J; Lip GY
    Int J Cardiol; 2016 Oct; 220():417-28. PubMed ID: 27390965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and emerging strategies in the management of venous thromboembolism: benefit-risk assessment of dabigatran.
    Fanola CL
    Vasc Health Risk Manag; 2015; 11():271-82. PubMed ID: 26064057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocytoclastic vasculitis as a rare dermatologic manifestation of Crohn's disease mimicking cellulitis: a case report.
    Buck M; Dumic I; McDermott W; Nordstrom C; Dawan S; Virata A; Martin S; Hudson A; Milovanovic T; Nordin T
    BMC Gastroenterol; 2020 Jul; 20(1):240. PubMed ID: 32727390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cinacalcet-induced leukocytoclastic vasculitis.
    Giannikopoulos G; Zorzou MP; Stamoulis I; Panagi G; Sitaras P; Georgopoulos I; Hadjileontis C; Malakos I; Kyriazis J
    Am J Kidney Dis; 2009 Aug; 54(2):e5-8. PubMed ID: 19560849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatologic Diagnosis: Leukocytoclastic Vasculitis.
    Einhorn J; Levis JT
    Perm J; 2015; 19(3):77-8. PubMed ID: 26176572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
    Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
    Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dabigatran for the prevention and treatment of thromboembolic disorders.
    Enriquez A; Baranchuk A; Redfearn D; Simpson C; Abdollah H; Michael K
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):529-40. PubMed ID: 25843430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam-induced leukocytoclastic vasculitis.
    Gupta M
    Indian J Pharmacol; 2017; 49(1):124-126. PubMed ID: 28458437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal paraneoplastic systemic leukocytoclastic vasculitis as a presenting feature of chronic lymphocytic leukemia.
    Lulla P; Bandeali S; Baker K
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S14-6. PubMed ID: 22035741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small vessel vasculitis of the skin.
    Micheletti RG; Werth VP
    Rheum Dis Clin North Am; 2015; 41(1):21-32, vii. PubMed ID: 25399937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytopenia induced by dabigatran: two case reports.
    Kang HG; Lee SJ; Chung JY; Cheong JS
    BMC Neurol; 2017 Jun; 17(1):124. PubMed ID: 28662704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.